Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists

V. Atkinson, G.V. Long, A.M. Menzies, G. Mcarthur, M.S. Carlino, Michael Millward, R. Roberts-Thomson, B. Brady, R. Kefford, A. Haydon, J. Cebon

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Web of Science)

    Fingerprint

    Dive into the research topics of 'Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists'. Together they form a unique fingerprint.

    Medicine & Life Sciences